NO20021436L - Nye forbindelser - Google Patents
Nye forbindelserInfo
- Publication number
- NO20021436L NO20021436L NO20021436A NO20021436A NO20021436L NO 20021436 L NO20021436 L NO 20021436L NO 20021436 A NO20021436 A NO 20021436A NO 20021436 A NO20021436 A NO 20021436A NO 20021436 L NO20021436 L NO 20021436L
- Authority
- NO
- Norway
- Prior art keywords
- new connections
- connections
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3046—Stomach, Intestines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/303—Liver or Pancreas
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9903895A SE9903895D0 (sv) | 1999-10-28 | 1999-10-28 | Novel compounds |
PCT/SE2000/002082 WO2001030854A2 (en) | 1999-10-28 | 2000-10-26 | Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20021436D0 NO20021436D0 (no) | 2002-03-22 |
NO20021436L true NO20021436L (no) | 2002-06-19 |
Family
ID=20417520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20021436A NO20021436L (no) | 1999-10-28 | 2002-03-22 | Nye forbindelser |
Country Status (18)
Country | Link |
---|---|
US (2) | US7189816B1 (no) |
EP (1) | EP1232186A2 (no) |
JP (1) | JP2003513024A (no) |
KR (1) | KR20020047288A (no) |
CN (1) | CN1229391C (no) |
AU (1) | AU773568B2 (no) |
BR (1) | BR0015103A (no) |
CA (1) | CA2386926A1 (no) |
EE (1) | EE200200224A (no) |
HU (1) | HUP0203297A2 (no) |
IL (1) | IL149245A0 (no) |
NO (1) | NO20021436L (no) |
NZ (1) | NZ518300A (no) |
PL (1) | PL354508A1 (no) |
RU (1) | RU2266298C2 (no) |
SE (1) | SE9903895D0 (no) |
WO (1) | WO2001030854A2 (no) |
ZA (1) | ZA200202221B (no) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0102327D0 (sv) | 2001-06-28 | 2001-06-28 | Active Biotech Ab | A novel engineered superantigen for human therapy |
AU2006232287B2 (en) | 2005-03-31 | 2011-10-06 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
JP5624276B2 (ja) | 2006-03-31 | 2014-11-12 | 中外製薬株式会社 | 抗体の血中動態を制御する方法 |
EP3345616A1 (en) | 2006-03-31 | 2018-07-11 | Chugai Seiyaku Kabushiki Kaisha | Antibody modification method for purifying bispecific antibody |
RU2489720C2 (ru) * | 2007-02-27 | 2013-08-10 | Сентоклон Интернэшнл Аб | Мультиплексная детекция опухолевых клеток с использованием панели агентов, связывающихся с внеклеточными маркерами |
KR102225009B1 (ko) | 2007-09-26 | 2021-03-08 | 추가이 세이야쿠 가부시키가이샤 | 항체 정상영역 개변체 |
JP5334319B2 (ja) * | 2007-09-26 | 2013-11-06 | 中外製薬株式会社 | Cdrのアミノ酸置換により抗体の等電点を改変する方法 |
GB0719231D0 (en) | 2007-10-03 | 2007-11-14 | Oxford Genome Sciences Uk Ltd | Protein |
BRPI0821110B8 (pt) | 2007-12-05 | 2021-05-25 | Chugai Pharmaceutical Co Ltd | anticorpo de neutralização de anti-nr10/il31ra, composição farmacêutica compreendendo o referido anticorpo e uso do mesmo |
TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
EP2409990A4 (en) | 2009-03-19 | 2013-01-23 | Chugai Pharmaceutical Co Ltd | VARIANT OF A CONSTANT ANTIBODY REGION |
EP2409991B1 (en) | 2009-03-19 | 2017-05-03 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
TW201041595A (en) | 2009-05-15 | 2010-12-01 | Chugai Pharmaceutical Co Ltd | Anti-axl antibody |
US10150808B2 (en) | 2009-09-24 | 2018-12-11 | Chugai Seiyaku Kabushiki Kaisha | Modified antibody constant regions |
EP2543730B1 (en) | 2010-03-04 | 2018-10-31 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
TWI452136B (zh) | 2010-11-17 | 2014-09-11 | 中外製藥股份有限公司 | A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation |
EP2679681B2 (en) | 2011-02-25 | 2023-11-15 | Chugai Seiyaku Kabushiki Kaisha | FcgammaRIIB-specific FC antibody |
TW201817744A (zh) | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之FcRn結合域的治療性抗原結合分子 |
WO2013047748A1 (ja) | 2011-09-30 | 2013-04-04 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
WO2015046467A1 (ja) | 2013-09-27 | 2015-04-02 | 中外製薬株式会社 | ポリペプチド異種多量体の製造方法 |
MA40764A (fr) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
KR102515796B1 (ko) | 2014-12-19 | 2023-03-30 | 추가이 세이야쿠 가부시키가이샤 | 항-c5 항체 및 그의 사용 방법 |
KR20180054923A (ko) | 2014-12-19 | 2018-05-24 | 추가이 세이야쿠 가부시키가이샤 | 항-마이오스타틴 항체, 변이체 Fc 영역을 함유하는 폴리펩타이드, 및 사용 방법 |
MX2017008978A (es) | 2015-02-05 | 2017-10-25 | Chugai Pharmaceutical Co Ltd | Anticuerpos que comprenden un dominio de union al antigeno dependiente de la concentracion ionica, variantes de la region fc, antiocuerpor de union a interleucina 8 (il-8) y usos de los mismos. |
EP4269440A3 (en) | 2015-02-27 | 2024-02-28 | Chugai Seiyaku Kabushiki Kaisha | Composition for treating il-6-related diseases |
JP7082484B2 (ja) | 2015-04-01 | 2022-06-08 | 中外製薬株式会社 | ポリペプチド異種多量体の製造方法 |
MA44334A (fr) | 2015-10-29 | 2018-09-05 | Novartis Ag | Conjugués d'anticorps comprenant un agoniste du récepteur de type toll |
US11359009B2 (en) | 2015-12-25 | 2022-06-14 | Chugai Seiyaku Kabushiki Kaisha | Anti-myostatin antibodies and methods of use |
BR112018009312A8 (pt) | 2015-12-28 | 2019-02-26 | Chugai Pharmaceutical Co Ltd | método para promover eficiência de purificação de polipeptídeo contendo região de fc |
RU2746754C2 (ru) | 2016-03-14 | 2021-04-20 | Чугаи Сейяку Кабусики Кайся | Индуцирующее повреждение клеток терапевтическое лекарственное средство, предназначенное для противораковой терапии |
US11053308B2 (en) | 2016-08-05 | 2021-07-06 | Chugai Seiyaku Kabushiki Kaisha | Method for treating IL-8-related diseases |
US11851486B2 (en) | 2017-05-02 | 2023-12-26 | National Center Of Neurology And Psychiatry | Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5320942A (en) * | 1987-02-19 | 1994-06-14 | Vito Quaranta | Method of diagnosing the presence of abnormal epithelial tissue using monoclonal antibodies to the A6 B4 cell surface protein |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
CA2078817A1 (en) | 1991-10-18 | 1993-04-19 | Beat A. Imhof | Anti-.alpha.6-integrin-antibodies |
US6113898A (en) * | 1995-06-07 | 2000-09-05 | Idec Pharmaceuticals Corporation | Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies |
GB9601081D0 (en) * | 1995-10-06 | 1996-03-20 | Cambridge Antibody Tech | Specific binding members for human transforming growth factor beta;materials and methods |
AU8691398A (en) * | 1997-08-04 | 1999-02-22 | Ixsys, Incorporated | Methods for identifying ligand specific binding molecules |
-
1999
- 1999-10-28 SE SE9903895A patent/SE9903895D0/xx unknown
-
2000
- 2000-10-26 CN CNB008148864A patent/CN1229391C/zh not_active Expired - Fee Related
- 2000-10-26 KR KR1020027005370A patent/KR20020047288A/ko not_active Application Discontinuation
- 2000-10-26 JP JP2001533851A patent/JP2003513024A/ja not_active Withdrawn
- 2000-10-26 EE EEP200200224A patent/EE200200224A/xx unknown
- 2000-10-26 HU HU0203297A patent/HUP0203297A2/hu unknown
- 2000-10-26 EP EP00976482A patent/EP1232186A2/en not_active Withdrawn
- 2000-10-26 CA CA002386926A patent/CA2386926A1/en not_active Abandoned
- 2000-10-26 US US10/088,639 patent/US7189816B1/en not_active Expired - Fee Related
- 2000-10-26 WO PCT/SE2000/002082 patent/WO2001030854A2/en active IP Right Grant
- 2000-10-26 BR BR0015103-3A patent/BR0015103A/pt not_active IP Right Cessation
- 2000-10-26 NZ NZ518300A patent/NZ518300A/en unknown
- 2000-10-26 IL IL14924500A patent/IL149245A0/xx unknown
- 2000-10-26 RU RU2002113741/13A patent/RU2266298C2/ru not_active IP Right Cessation
- 2000-10-26 PL PL00354508A patent/PL354508A1/xx not_active Application Discontinuation
- 2000-10-26 AU AU14248/01A patent/AU773568B2/en not_active Ceased
-
2002
- 2002-03-19 ZA ZA200202221A patent/ZA200202221B/en unknown
- 2002-03-22 NO NO20021436A patent/NO20021436L/no not_active Application Discontinuation
-
2006
- 2006-11-08 US US11/594,126 patent/US20070112179A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2386926A1 (en) | 2001-05-03 |
WO2001030854A3 (en) | 2001-12-06 |
IL149245A0 (en) | 2002-12-01 |
NO20021436D0 (no) | 2002-03-22 |
BR0015103A (pt) | 2002-07-16 |
KR20020047288A (ko) | 2002-06-21 |
SE9903895D0 (sv) | 1999-10-28 |
US20070112179A1 (en) | 2007-05-17 |
US7189816B1 (en) | 2007-03-13 |
AU1424801A (en) | 2001-05-08 |
HUP0203297A2 (hu) | 2003-01-28 |
NZ518300A (en) | 2004-03-26 |
PL354508A1 (en) | 2004-01-26 |
JP2003513024A (ja) | 2003-04-08 |
ZA200202221B (en) | 2003-05-28 |
EE200200224A (et) | 2003-06-16 |
CN1384840A (zh) | 2002-12-11 |
EP1232186A2 (en) | 2002-08-21 |
RU2266298C2 (ru) | 2005-12-20 |
WO2001030854A2 (en) | 2001-05-03 |
AU773568B2 (en) | 2004-05-27 |
CN1229391C (zh) | 2005-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20014518D0 (no) | Nye forbindelser | |
DK1202994T3 (da) | Nye forbindelser | |
NO20021436D0 (no) | Nye forbindelser | |
NO20026064L (no) | Nye forbindelser | |
NO20023932L (no) | Nye forbindelser | |
NO20033715D0 (no) | Nye sammensetninger | |
NO20016115D0 (no) | Substituerte heterocykelkondenserte gamma-karboliner | |
NO20015383L (no) | Nye forbindelser | |
NO20020810D0 (no) | Nye fenylpiperaziner | |
NO20025151D0 (no) | Nye forbindelser | |
DK1237857T3 (da) | Nye Phenalkyloxyphenylderivater | |
NO20031141D0 (no) | Nye forbindelser | |
NO20015074L (no) | Nye sammensetninger | |
NO20010860D0 (no) | Nye forbindelser | |
NO20010861D0 (no) | Nye forbindelser | |
NO20026162D0 (no) | Nye forbindelser | |
NO20026081D0 (no) | Nye forbindelser | |
NO20030274L (no) | Nye aryleten-sulfonamider | |
NO995945D0 (no) | Nye forbindelser | |
NO20015374L (no) | Nye forbindelser | |
NO20014629D0 (no) | Nye forbindelser | |
NO20022927D0 (no) | Substituerte pyrrazoler | |
NO20016273D0 (no) | Nye forbindelser | |
NO20010584D0 (no) | Nye forbindelser | |
NO20011262D0 (no) | Nye forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |